Skip to content

Ardelyx ARDX Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
Bausch Health Companies logo
Bausch Health CompaniesBHC
AbbVie logo
AbbVieABBV
XER
Xeris Biopharma Holdings, Inc.XERS
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's deferred tax assets and other non-current assets?
Ardelyx (ARDX) reported deferred tax assets and other non-current assets of $6.68M in Q1 2026.
How has Ardelyx's deferred tax assets and other non-current assets changed year-over-year?
Ardelyx's deferred tax assets and other non-current assets decreased by 2.0% year-over-year, from $6.82M to $6.68M.
What is the long-term trend for Ardelyx's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Ardelyx's deferred tax assets and other non-current assets has grown at a 52.6% compound annual growth rate (CAGR), from $1.8M to $14.94M.